CLINICAL_TRIALS
trial_result
· 2017-02-01
Clinical Trial Update: Golgi Protein for HCC Diagnosis
Summary
The trial evaluated a Golgi protein as a diagnostic tool for screening hepatocellular carcinoma and has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Ain Shams University | Conditions: Screening for Hepatocellular Carcinoma | Status: COMPLETED